CCM

Concord Medical Services Holdings Ltd

Add to Watchlist

Advanced Chart

5.225

-0.225(-4.128%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

5.2247

Open

5.2247

VWAP

5.45

Vol

611.00

Mkt Cap

22.68M

Low

5.2247

Amount

3.33K

EV/EBITDA(TTM)

Total Shares

43.42M

1.02B

EV/OCF(TTM)

P/S(TTM)

0.05

Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The Company operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The Company mainly conducts its business in the domestic market.

1 Analyst Rating

-4.30% Downside

Wall Street analysts forecast CCM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCM is 5.00 USD with a low forecast of 5.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

1 Hold

0 Sell

Hold

-4.30% Downside

Current: 5.225

Low

5.00

Averages

5.00

High

5.00

-4.30% Downside

Current: 5.225

Low

5.00

Averages

5.00

High

5.00

The End

No Data

Valuation Metrics

The current forward P/E ratio for Concord Medical Services Holdings Ltd (CCM.N) is -19.46, compared to its 5-year average forward P/E of -34.10. For a more detailed relative valuation and DCF analysis to assess Concord Medical Services Holdings Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-34.10

Current PE

-19.46

Overvalued PE

-15.44

Undervalued PE

-52.76

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

16.86

Current EV/EBITDA

65.75

Overvalued EV/EBITDA

98.99

Undervalued EV/EBITDA

-65.27

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.66

Current PS

0.51

Overvalued PS

2.81

Undervalued PS

0.51